The article presents analysis of clinical trials registers which involves clinical trials evaluating small molecules therapeutics, biological drugs, adjuvants, and vaccines, and compliance with the European Commission requirement for trials. It mentions that results of studies funded by large drug companies and NIH were more likely to appear on clinicaltrials.gov than those from non-profit funders, which were published mainly as journal articles.